Organogenesis Holdings Dividends
| ORGO Stock | USD 3.90 0.06 1.52% |
As of the 29th of November 2024, Dividend Paid And Capex Coverage Ratio is likely to grow to 1.33, while Dividends Paid is likely to drop about 554 K. Organogenesis Holdings' past performance could be the main factor of why investors trade Organogenesis Holdings stock today. Investors should clearly understand every aspect of the Organogenesis Holdings dividend schedule, including its future sustainability, and how it might impact an overall investment strategy. This tool is helpful to digest Organogenesis Holdings' dividend schedule and payout information. Organogenesis Holdings dividends can also provide a clue to the current valuation of Organogenesis Holdings.
| Last Reported | Projected for Next Year | ||
| Dividends Paid | 583.2 K | 554 K | |
| Dividend Paid And Capex Coverage Ratio | 1.27 | 1.33 |
Organogenesis |
Investing in stocks that pay dividends is one of many strategies that are good for long-term investments. Ex-dividend dates are significant because investors in Organogenesis Holdings must own a stock before its ex-dividend date to receive its next dividend.
Organogenesis Holdings Dividends Paid Over Time
Today, most investors in Organogenesis Holdings Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Organogenesis Holdings' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's dividends paid growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Organogenesis Holdings dividends paid as a starting point in their analysis.
The total amount of dividends that a company has paid out to its shareholders over a specific period. Dividends Paid |
| Timeline |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Organogenesis Holdings. If investors know Organogenesis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Organogenesis Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 3.5 | Earnings Share (0.05) | Revenue Per Share 3.446 | Quarterly Revenue Growth 0.061 | Return On Assets 0.0164 |
The market value of Organogenesis Holdings is measured differently than its book value, which is the value of Organogenesis that is recorded on the company's balance sheet. Investors also form their own opinion of Organogenesis Holdings' value that differs from its market value or its book value, called intrinsic value, which is Organogenesis Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Organogenesis Holdings' market value can be influenced by many factors that don't directly affect Organogenesis Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Organogenesis Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if Organogenesis Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Organogenesis Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.